1.1 Articolo in rivista

1.1 Articolo in rivista: [37655] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 10.521 a 10.540 di 37.655

Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical praticeguidelineupdate

2019-01-01 Bohlius, J; Bohlke, K; Castelli, R; Djulbegovic, B; Lustberg, Mb; Martino, M; Mountzios, G; Peswani, N; Porter, L; Tanaka, Tn; Trifirò, G; Yang, H; Lazo-Langner, A.

Anti-t-PA antibodies in acute myocardial infarction after thrombolysis with rt-PA

2010-01-01 Cugno, M.; Castelli, R.; Bisiani, G.; Griffini, S.; Meroni, P. L.

Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization

2015-01-01 Castelli, R.; Cugno, M.; Gianelli, U.; Pancrazzi, A.; Vannucchi, A. M.

The impact of anaemia, transfusion dependency, commorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes

2018-01-01 Castelli, R; Schiavon, R; Lambertenghi Deliliers, G.

Lymphoproliferative disease and acquired C1 inhibitor deficiency

2007-01-01 Castelli, R; Deliliers, Dl; Zingale, Lc; Pogliani, Em; Cicardi, M.

Syncope in patients with pulmonary embolism: comparison between patients with syncope as the presenting symptom of pulmonary embolism and patients with pulmonary embolism without syncope

2003-01-01 Castelli, R; Tarsia, P; Tantardini, C; Pantaleo, G; Guariglia, A; Porro, F.

Biosimilar epoetin in elderly patients with low risk myelodisplastic syndromes improves anaemia, quality of life and brain function

2014-01-01 Castelli, R; Deliliers, Gl; Colombo, R; Moreo, G; Gallipoli, P; Pantaleo, G

The impact of an aging population on the diagnosis of pulmonary embolism: comparison of young and elderly patients

2009-01-01 Castelli, R; Bergamaschini, L; Sailis, P; Pantaleo, G; Porro, F.

Complement Activation in Patients With Immune Thrombocytopenic Purpura According to Phases of Disease Course

2020-01-01 Castelli, R; LAMBERTENGHI DELILIERS, G; Gidaro, A; Cicardi, M; Bergamaschini, L.

High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation

2018-01-01 Castelli, Roberto; Gallipoli, Paolo; Paolo;, Schiavon; Teatini, Thomas; Deliliers, Giorgio Lambertenghi; Giorgio Lambertenghi;, Bergamaschini

Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management

2006-01-01 Zingale, Lc; Castelli, R; Zanichelli, A; Cicardi, M

Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation

2019-01-01 Castelli, Roberto; Gallipoli, Paolo; Schiavon, Riccardo; Teatini, Thomas; Deliliers, Giorgio Lambertenghi; Bergamaschini, Luigi

The heparins and cancer: review of clinical trials and biological properties

2004-01-01 Castelli, R; Porro, F; Tarsia, P.

Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor

1998-01-01 De Filippi, F; Castelli, R; Cicardi, M; Soffredini, R; Rumi, Mg; Silini, E; Mannucci, Pm; Colombo, M.

Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot Study

2020-01-01 Castelli, R; Bergamaschini, L; Teatini, T; Cilumbriellol, ; Schiavon, R; Gallipoli, P; LAMBERTENGHI DELILIERS, G.

First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas

2018-01-01 Castelli, Roberto; Roberto*;, Bergamaschini; Deliliers, Giorgio Lambertenghi

Managment of anemia in low risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents

2018-01-01 Castelli, R; Schiavon, R; Rossi, V; Lambertenghi Deliliers, G

High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency

2016-01-01 Castelli, R.; Wu, M. A.; Arquati, M.; Zanichelli, A.; Suffritti, C.; Rossi, D.; Cicardi, M.

Immunomodulatory drugs : new options for the treatment of myelodysplastic syndromes

2013-01-01 Castelli, R.; Cassin, R.; Cannavò, A.; Cugno, M.

Unusual severe development of common B lymphoblastic leukemia in Gaucher disease type I

2006-01-01 Castelli, R; Cassinerio, E; Iurlo, A; Zanella, A; Gianelli, U; Cappellini, Md

Titolo	Data di pubblicazione	Autore(i)
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical praticeguidelineupdate	1-gen-2019	Bohlius, J; Bohlke, K; Castelli, R; Djulbegovic, B; Lustberg, Mb; Martino, M; Mountzios, G; Peswani, N; Porter, L; Tanaka, Tn; Trifirò, G; Yang, H; Lazo-Langner, A.
Anti-t-PA antibodies in acute myocardial infarction after thrombolysis with rt-PA	1-gen-2010	Cugno, M.; Castelli, R.; Bisiani, G.; Griffini, S.; Meroni, P. L.
Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization	1-gen-2015	Castelli, R.; Cugno, M.; Gianelli, U.; Pancrazzi, A.; Vannucchi, A. M.
The impact of anaemia, transfusion dependency, commorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes	1-gen-2018	Castelli, R; Schiavon, R; Lambertenghi Deliliers, G.
Lymphoproliferative disease and acquired C1 inhibitor deficiency	1-gen-2007	Castelli, R; Deliliers, Dl; Zingale, Lc; Pogliani, Em; Cicardi, M.
Syncope in patients with pulmonary embolism: comparison between patients with syncope as the presenting symptom of pulmonary embolism and patients with pulmonary embolism without syncope	1-gen-2003	Castelli, R; Tarsia, P; Tantardini, C; Pantaleo, G; Guariglia, A; Porro, F.
Biosimilar epoetin in elderly patients with low risk myelodisplastic syndromes improves anaemia, quality of life and brain function	1-gen-2014	Castelli, R; Deliliers, Gl; Colombo, R; Moreo, G; Gallipoli, P; Pantaleo, G
The impact of an aging population on the diagnosis of pulmonary embolism: comparison of young and elderly patients	1-gen-2009	Castelli, R; Bergamaschini, L; Sailis, P; Pantaleo, G; Porro, F.
Complement Activation in Patients With Immune Thrombocytopenic Purpura According to Phases of Disease Course	1-gen-2020	Castelli, R; LAMBERTENGHI DELILIERS, G; Gidaro, A; Cicardi, M; Bergamaschini, L.
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation	1-gen-2018	Castelli, Roberto; Gallipoli, Paolo; Paolo;, Schiavon; Teatini, Thomas; Deliliers, Giorgio Lambertenghi; Giorgio Lambertenghi;, Bergamaschini
Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management	1-gen-2006	Zingale, Lc; Castelli, R; Zanichelli, A; Cicardi, M
Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation	1-gen-2019	Castelli, Roberto; Gallipoli, Paolo; Schiavon, Riccardo; Teatini, Thomas; Deliliers, Giorgio Lambertenghi; Bergamaschini, Luigi
The heparins and cancer: review of clinical trials and biological properties	1-gen-2004	Castelli, R; Porro, F; Tarsia, P.
Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor	1-gen-1998	De Filippi, F; Castelli, R; Cicardi, M; Soffredini, R; Rumi, Mg; Silini, E; Mannucci, Pm; Colombo, M.
Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot Study	1-gen-2020	Castelli, R; Bergamaschini, L; Teatini, T; Cilumbriellol, ; Schiavon, R; Gallipoli, P; LAMBERTENGHI DELILIERS, G.
First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas	1-gen-2018	Castelli, Roberto; Roberto;, Bergamaschini; Deliliers, Giorgio Lambertenghi*
Managment of anemia in low risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents	1-gen-2018	Castelli, R; Schiavon, R; Rossi, V; Lambertenghi Deliliers, G
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency	1-gen-2016	Castelli, R.; Wu, M. A.; Arquati, M.; Zanichelli, A.; Suffritti, C.; Rossi, D.; Cicardi, M.
Immunomodulatory drugs : new options for the treatment of myelodysplastic syndromes	1-gen-2013	Castelli, R.; Cassin, R.; Cannavò, A.; Cugno, M.
Unusual severe development of common B lymphoblastic leukemia in Gaucher disease type I	1-gen-2006	Castelli, R; Cassinerio, E; Iurlo, A; Zanella, A; Gianelli, U; Cappellini, Md

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 10.521 a 10.540 di 37.655

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext33541
open3617
reserved293
restricted136
partially open66
mixed2